A groundbreaking trial is testing the ability to reverse death in patients that have been declared brain dead.
The study explores biological regeneration using modern technologies and medicine to try restore brain function.
A team at the American regenerative healthcare company Bioquark will test 20 patients who have been declared clinically dead from a traumatic brain injury.
We are looking, for the first time ever, to investigate the principles of regeneration through modern technologies of regenerative medicine in the brain stem of individuals who have recently been declared brain dead, but still on life support.— Ira Pastor, CEO of Bioquark
Bioquark CEO Ira Pastor explains that the goal is to revive brain stem functions using human cell therapy.
We're trying to turn back time in the tissue that remains, following the injury in the brain...to create new nervous and vascular tissue - ultimately to regrow the entire central nervous system back to perfect.— Ira Pastor, Bioquark CEO
Listen to the full conversation from CapeTalk's Breakfast with Kieno Kammies: